For citations:
Fateeva EV, Smirnova LV, Tarakanova VV, Basayeva TA, Kharitonov DV, Gaponova NM, Terekhova YY, Mamchenkova EV, Slavskaya VA. Pathogenetic therapy with ivacaftor + tezacaftor + elexacaftor plus ivacaftor: Assessment of efficacy and safety of switching within a single INN in children with cystic fibrosis in the Yaroslavl and Tula regions. Meditsinskiy sovet = Medical Council. (In Russ.) https://doi.org/10.21518/ms2026-283
JATS XML
































